Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - oxytetracycline; flunixin - solution for injection - oxytetracycline, combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - thiamazole - oral solution - thiamazole

European Union - English - EMA (European Medicines Agency)

dechra regulatory b.v. - desoxycortone pivalate - corticosteroids for systemic use - dogs - for use as replacement therapy for mineralocorticoid deficiency in dogs with primary hypoadrenocorticism (addison's disease).

European Union - English - EMA (European Medicines Agency)

dechra regulatory b.v. - maropitant - alimentary tract and metabolism, other antiemetics - cats; dogs - dogs:for the treatment and prevention of nausea induced by chemotherapyfor the prevention of vomiting except that induced by motion sicknessfor the treatment of vomiting, in combination with other supportive measuresfor the prevention of perioperative nausea and vomiting and improvement in recovery from general anaesthesia after use of the μ-opiate receptor agonist morphinecats:for the prevention of vomiting and the reduction of nausea, except that induced by motion sicknessfor the treatment of vomiting, in combination with other supportive measures.

European Union - English - EMA (European Medicines Agency)

dechra regulatory b.v. - mirtazapine - psychoanaleptics, antidepressants in combination with psycholeptics - cats - for bodyweight gain in cats experiencing poor appetite and weight loss resulting from chronic medical conditions.

European Union - English - EMA (European Medicines Agency)

dechra regulatory b.v. - tulathromycin - antibacterials for systemic use - cattle; pigs; sheep - cattle: treatment and metaphylaxis of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment.treatment of infectious bovine keratoconjunctivitis (ibk) associated with moraxella bovis susceptible to tulathromycin.pigs: treatment and metaphylaxis of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, mycoplasma hyopneumoniae, haemophilus parasuis and bordetella bronchiseptica susceptible to tulathromycin. the presence of the disease in the herd should be established before metaphylactic treatment. the product should only be used if pigs are expected to develop the disease within 2–3 days.sheep: treatment of the early stages of infectious pododermatitis (foot rot) associated with virulent dichelobacter nodosus requiring systemic treatment.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dechra veterinary products (australia) pty. ltd. - trimethoprim; sulfadimidine - oral powder, pre-mix - trimethoprim pyrimidine active 90.0 mg/g; sulfadimidine sulfanyl active 450.0 mg/g - antibiotic & related

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - lidocaine hydrochloride monohydrate - laryngopharyngeal spray, solution - 20 milligram(s)/millilitre - lidocaine

Ireland - English - HPRA (Health Products Regulatory Authority)

dechra regulatory b.v. - pimobendan - oral solution - 3.5 milligram(s)/millilitre - pimobendan

Canada - English - Health Canada

dechra regulatory bv - tulathromycin - solution - 100mg - tulathromycin 100mg - cattle; swine (pigs); sheep